We provided free CVD risks screening to ~ 300 people in my remote hometown of Jirapa, Ghana. >80% were 1st time BP checks. Many were hypertensive and were initiated on meds. Join us! @SethShayMartin @CiccaroneCenter @akoma_plus @hopkinsheart

Exciting symposium on arrhythmogenic cardiomyopathy (#ACM #ARVC). Working towards gene-specific criteria with many of my great colleagues on day 1: @JuliaCTourigny @HughCalkinsMD @ASaguner @Cristinabasso64 @MarioDelmar3 @COpbergen @KristinaHaugaa @jpkaski

PASSED #echo boards! Huge relief! Three thoughts (As a current trainee and prior teacher): ✅ If you failed, I'm sorry. You've come really far just to take the test ✅ If pass rate is ~80% - 81% last year - test quality is poor and/or fellow education is poor. Either way, for a certification exam that's unacceptable. For context, Step 2 pass rate is 97% ✅ 9 weeks for result. Say they need time to check qs. If that's necessary the qs were poorly constructed to begin with. Consider above Question: How do you join NBE to address this?

👆🏼my editorial on the new DSP risk score academic.oup.com/eurheartj/a… by @RTCarrick @gasperettimd and colleagues

Pretty shocking from @NEJM Effectively disguising an ad like this is Buzzfeed or something Certainly more explanation needed

Prevalence of pathogenic/likely pathogenic variants of CMP associated genes in complicated myocarditis 22% in adults and 45% in children! Sarcomeric gene variants more prevalent in complicated myocarditis. #JACCHF @JACCJournals jacc.org/doi/10.1016/j.jchf.… jacc.org/doi/10.1016/j.jchf.…

So appreciative of @drjohnm for covering the suspension of RECOVER IV in this episode DanGer Shock was extremely exciting, but I can't believe this was cancelled on the results of one trial Really wonder about conflicts of interest here medscape.com/viewarticle/100…

Need to get this flag for my office

Our fellows took part in the Bruce protocol challenge! A major shout out to @RTCarrick & David Polhemus for completing all 21 minutes of the challenge!! @HopkinsPCCM we heard you also like to stress test 👀🤝👀?

Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Hypertrophic Cardiomyopathy Patients with Atrial Fibrillation @EthanRowin heartrhythmjournal.com/artic…

Great work by @AmroAglanMD @AymanFathMD1 and team evaluating if LAA closure is effective to prevent strokes in HCM patients with AF

#hrs24 kicking off another hrs! Poster session with the cardiac ep society, presenting on ECG-DL augmented ARVC diagnosis. Great turnout!

What a sad reflection of our society that @johnshopkins is now requiring a weapons search to enter the building. Going to work feels like going through the TSA. Take my stethoscope out of my bag? What theater, so depressing

Awesome having my long-time mentor and collaborator @EthanRowin drop some knowledge on HCM-related afib for us at @hopkinsheart grand rounds!

Congrats @RTCarrick and the other research award winners of the JHU Department of Medicine & Whiting School of Engineering 2024 RESEARCH RETREAT

I enjoyed learning about the potential for home-based cardiac rehab and virtual health coaching to improve heart health from Asma Rayani and Ali Kassamali. ⁦@DoctorMarvelMD⁩ ⁦@SethShayMartin⁩ ⁦@CorrieHealth⁩ ⁦@CiccaroneCenter⁩ ⁦@hopkinsheart⁩

Congratulations to ⁦@hopkinsheart⁩ faculty ⁦@luigiadamomdphd⁩ for receiving the 2024 Brancati Excellence in Mentoring Award! ⁦@JLovellMD⁩ ⁦@rblument1⁩

Congratulations to ⁦@hopkinsheart⁩ #FIT #RickCarrick for winning the W. Leigh Thompson Excellence in Research Award (Clinical Fellow) at #HopkinsResearchRetreat for his team’s work on ECG in HCM. ⁦@JohnsHopkinsDOM⁩ ⁦@HopkinsEngineer⁩ ⁦@tabrahammd⁩

I can't be the only one living vicariously through my non-PhD friends 😂

🎯 VT ablation in desmoplakin-ACM patients is effective in reducing the VA burden of the disease, but recurrences are common. ⚡️ Most VT circuits are epicardial, with both LV and RV low voltage abnormalities. #JACCEP @JACCJournals @gasperettimd jacc.org/doi/10.1016/j.jacep…